Efficacy of Nanoparticle Albumin-Bound Paclitaxel (nab-PTX) Monotherapy Can Be Improved after Treatment with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: Long-Term Follow-Up and Updated Analysis of Two Previous Prospective Clinical Studies.
Koki NakashimaYukihiro UmedaYoshiki DemuraTomoaki SonodaToshihiko TadaMakiko YamaguchiMasaki AnzaiMaiko KadowakiMasahiro OiChisato HonjoMiho MitsuiYuko WasedaTamotsu IshizukaPublished in: Oncology (2024)
Nab-PTX monotherapy may be an effective subsequent treatment option after ICI treatment.